Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
V.AFM: Record Fy2024 & Q4 ‘24 Tin Production Fy2025 Production Guidance Exploration Success (click to learn more) Noble Acquires Property with Significant Uranium, Rare Earth, Phosphorus & Silver Minerlaization (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Senti Biosciences Inc SNTI

Healthcare Biotechnology
Senti Biosciences, Inc. is a clinical-stage biotechnology company. It is developing cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. It is focused on off-the-shelf CAR-NK cell therapy programs for oncology indications. Its lead product candidate, SENTI-202, is a potential Logic Gated off-the-shelf CAR-NK cell therapy... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SNTI)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into Senti Biosciences Inc

Accesswire 1 day ago

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc

Accesswire 2 days ago

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into Senti Biosciences Inc.

Accesswire 3 days ago

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into Senti Biosciences Inc.

Accesswire 4 days ago

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into Senti Biosciences Inc

Accesswire 5 days ago

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into Senti Biosciences Inc.

Accesswire 8 days ago

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into Senti Bioscience Inc

Accesswire 9 days ago

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into Senti Biosciences Inc

Accesswire 10 days ago

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into Senti Biosciences Inc

Accesswire 11 days ago
View More News ››

Opinion & Analysis (NDAQ:SNTI)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SNTI)

Senti Bio Announces First Patient Dosed in Clinical Trial of

Just In: $SNTI Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration with...
whytestocks - December 16, 2024

$SNTI Slips, $MYNZ Builds for the Future

$SNTI falls 29% to $7.14 amid concerns in synthetic biology progress. Meanwhile, $MYNZ, post-reverse split, is regaining strength...
SkyProfit12 - December 4, 2024

SNTI Kaboom!! SPAI News

SNTI Kaboom!! SPAI News
10QKing - December 2, 2024

Senti Biosciences, Inc. Announces Oversubscribed $37.6 Milli

NEWS: $SNTI Senti Biosciences, Inc. Announces Oversubscribed $37.6 Million Private Placement Equity FinancingSOUTH SAN FRANCISCO, Calif....
whytestocks - December 2, 2024

Senti Biosciences, Inc. (NASDAQ:SNTI): A Promising Gene Circ

http://beyondspx.com/2024/08/01/senti-biosciences-inc-nasdaqsnti-a-promising-gene-circuit-platform-with-significant-potential/
MikeTester - August 2, 2024
View more Bullboard ››

Forge Resources Corp.

Forge Resources Corp.

Forge Resources Corp. is a junior exploration company. The Company is engaged in the business of the exploration and ...
View More »